InspireMD, Inc.
NSPR
22 insider filings · Latest: May 27, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | May 12 11:35 PM | Paul StukaDirector | Purchase | 10,000 | $1.19 | $11.9K | 632,871(D) | View → |
| May 8, 2026 | May 12 11:35 PM | Paul StukaDirector | Purchase | 65,626 | $1.16 | $76.1K | 622,871(D) | View → |
| May 7, 2026 | May 8 9:08 PM | Scott R. WardDirector | Purchase | 73,255 | $1.15 | $84.2K | 237,096(D) | View → |
| May 6, 2026 | May 8 9:08 PM | Scott R. WardDirector | Purchase | 15,995 | $1.15 | $18.4K | 163,841(D) | View → |
| May 7, 2026 | May 8 9:05 PM | Paul StukaDirector | Purchase | 6,378 | $1.15 | $7.3K | 531,599(D) | View → |
| May 6, 2026 | May 8 9:05 PM | Paul StukaDirector | Purchase | 1,517 | $1.12 | $1.7K | 525,221(D) | View → |
| May 7, 2026 | May 8 9:03 PM | Gary S RoubinDirector | Purchase | 90,000 | $1.18 | $106.2K | 834,478(D) | View → |
| Dec 9, 2025 | Feb 23 9:05 PM | Paul StukaDirector | Purchase | 2,710 | $1.81 | $4.9K | 391,628(D) | View → |
| Feb 2, 2026 | Feb 2 10:01 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 2,000 | $1.60 | $3.2K | 1,139,177(D) | View → |
| Jan 30, 2026 | Feb 2 10:01 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 2,900 | $1.63 | $4.7K | 1,141,177(D) | View → |
| Jan 29, 2026 | Feb 2 10:01 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 5,000 | $1.65 | $8.3K | 1,144,077(D) | View → |
| Jan 28, 2026 | Feb 2 10:01 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 12,395 | $1.65 | $20.5K | 1,149,077(D) | View → |
| Jan 27, 2026 | Feb 2 10:01 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 4,781 | $1.66 | $8.0K | 1,161,472(D) | View → |
| Jan 22, 2026 | Feb 2 10:01 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 8,411 | $1.57 | $13.2K | 1,166,253(D) | View → |
| Jan 21, 2026 | Feb 2 10:01 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 17,593 | $1.62 | $28.6K | 1,174,664(D) | View → |
| Jan 20, 2026 | Feb 2 10:01 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 2,955 | $1.59 | $4.7K | 1,192,257(D) | View → |
| Jan 16, 2026 | Feb 2 10:01 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 2,250 | $1.61 | $3.6K | 1,195,212(D) | View → |
| Jan 15, 2026 | Feb 2 10:01 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 2,909 | $1.58 | $4.6K | 1,197,462(D) | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | Dec 31 9:15 PM | Kathryn ArnoldDirector | Grant/Award | 26,276 | $1.89 | 111,221(D) | View → |